Literature DB >> 19750261

Can aspirin protect or at least attenuate gentamicin ototoxicity in humans?

Fatholah Behnoud1, Khashayar Davoudpur, Mohammad T Goodarzi.   

Abstract

OBJECTIVE: To investigate and prove that Aspirin as an antioxidant protects, or at least attenuates Gentamicin ototoxicity in humans.
METHODS: A prospective, randomized, double-blind trial was conducted in 60 patients that completed all requirements. This study was conducted in the Department of Otolaryngology and Orthopedics, Besat Hospital, Hamadan University of Medical Sciences, Hamadan, Iran, between December 2007 and November 2008. The patients were divided into 2 groups, the experimental and the control groups that were similar with respect to gender, age, and weight. The treatment group received 1.5 g/day (500 mg every 8 hours) Aspirin, and the control group received placebo similar to the other group.
RESULTS: Comparison of the pure tone audiometry (PTA) at 1000 Hertz (Hz) (p=0.03), 2000 Hz (p=0.003), 4000 Hz (p=0.001), and 8000 Hz (p=0.0010) showed significant differences between mean of PTA at the beginning, 8th, and 15th day. The threshold of PTA at 250 Hz was significantly different only at the 8th and 15th day (p=0.004), also at the frequency of 500 Hz, the difference between the beginning within 15th day and 8th day with 15th day was significant (p=0.001).
CONCLUSION: In the present study, we had shown that Aspirin can protect the ototoxic effect of gentamicin in patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19750261

Source DB:  PubMed          Journal:  Saudi Med J        ISSN: 0379-5284            Impact factor:   1.484


  11 in total

Review 1.  New developments in aminoglycoside therapy and ototoxicity.

Authors:  Jing Xie; Andra E Talaska; Jochen Schacht
Journal:  Hear Res       Date:  2011-05-27       Impact factor: 3.208

2.  Interaction of gentamicin with phosphatidylserine/phosphatidylcholine mixtures in adsorption monolayers and thin liquid films: morphology and thermodynamic properties.

Authors:  Georgi D Georgiev; Georgi As Georgiev; Z Lalchev
Journal:  Eur Biophys J       Date:  2010-03-04       Impact factor: 1.733

Review 3.  Ubiquitous aspirin: a systematic review of its impact on sensorineural hearing loss.

Authors:  Meghann Elizabeth Kyle; James C Wang; Jennifer J Shin
Journal:  Otolaryngol Head Neck Surg       Date:  2014-10-30       Impact factor: 3.497

4.  Effects of Combined Gentamicin and Furosemide Treatment on Cochlear Macrophages.

Authors:  Liana Sargsyan; Austin R Swisher; Alisa P Hetrick; Hongzhe Li
Journal:  Int J Mol Sci       Date:  2022-07-01       Impact factor: 6.208

Review 5.  Cisplatin and aminoglycoside antibiotics: hearing loss and its prevention.

Authors:  Jochen Schacht; Andra E Talaska; Leonard P Rybak
Journal:  Anat Rec (Hoboken)       Date:  2012-10-08       Impact factor: 2.064

6.  Assessment of nutrient supplement to reduce gentamicin-induced ototoxicity.

Authors:  C G Le Prell; C Ojano-Dirain; E W Rudnick; M A Nelson; S J DeRemer; D M Prieskorn; J M Miller
Journal:  J Assoc Res Otolaryngol       Date:  2014-03-04

7.  Mechanisms of aminoglycoside ototoxicity and targets of hair cell protection.

Authors:  M E Huth; A J Ricci; A G Cheng
Journal:  Int J Otolaryngol       Date:  2011-10-25

8.  Toll-like Receptor 4 Signaling and Downstream Neutrophilic Inflammation Mediate Endotoxemia-Enhanced Blood-Labyrinth Barrier Trafficking.

Authors:  Zachary D Urdang; Jessica L Bills; David Y Cahana; Leslie L Muldoon; Edward A Neuwelt
Journal:  Otol Neurotol       Date:  2020-01       Impact factor: 2.619

Review 9.  Resolution of Cochlear Inflammation: Novel Target for Preventing or Ameliorating Drug-, Noise- and Age-related Hearing Loss.

Authors:  Gilda M Kalinec; Gwen Lomberk; Raul A Urrutia; Federico Kalinec
Journal:  Front Cell Neurosci       Date:  2017-07-07       Impact factor: 5.505

Review 10.  Age-related hearing impairment and the triad of acquired hearing loss.

Authors:  Chao-Hui Yang; Thomas Schrepfer; Jochen Schacht
Journal:  Front Cell Neurosci       Date:  2015-07-27       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.